Inventor · disambiguated record
Jaclyn Kay Anderson
Also filed as: ANDERSON JACLYN KAY
2 granted patents·4 pending applications·26 citations·filing 2020–2023
59Inventor score
Files withABBVIE INC6
Top patents by PatentIndex Score
6 records- 0196US11365198B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2021·Granted Jun 21, 2022·25 cites·22 claims
- 0291US11993605B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2023·Granted May 28, 2024·1 cites·24 claims
- 0374US2024216367A1Treating spondyloarthritic and psoriatic conditions with upadacitinibABBVIE INC·Filed 2023·Application pending·0 cites
- 0471US2023364080A1Treating spondyloarthritic and psoriatic conditions with upadacitinibABBVIE INC·Filed 2022·Application pending·0 cites
- 0566US2022281882A1PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOFABBVIE INC·Filed 2022·Application pending·0 cites
- 0662US2021228575A1Treating spondyloarthritic and psoriatic conditions with upadacitinibABBVIE INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jaclyn Kay Anderson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →